申请人:Engelhardt Harald
公开号:US20090306067A1
公开(公告)日:2009-12-10
The present invention encompasses compounds of general formula (1) wherein Q and R
1
to R
4
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and their use for preparing a pharmaceutical composition having the above-mentioned properties.
本发明涵盖了一般式(1)中Q和R1至R4如权利要求1所定义的化合物,适用于治疗由过度或异常细胞增殖所表征的疾病,并用于制备具有上述性质的制药组合物。